Synthesis and initial characterization of FGFR3 transmembrane domain: Consequences of sequence modifications

Medicine & Life Sciences

• Receptor, Fibroblast Growth Factor, Type 3 100%
• Receptor Protein-Tyrosine Kinases 69%
• Dimerization 42%
• Peptides 23%
• lysyllysine 16%
• Solid-Phase Synthesis Techniques 14%
• Hydrophobic and Hydrophilic Interactions 10%
• Solubility 9%
• Lysine 9%
• High Pressure Liquid Chromatography 7%
• Gels 7%
• Signal Transduction 7%
• Cell Membrane 6%
• Amino Acids 6%
• Lipids 6%
• Pathology 5%
• Phenotype 5%
• Membranes 5%
• Mutation 5%

Chemical Compounds

• Tyrosine 59%
• Modification 36%
• Dimerization 33%
• Signal Transduction 10%
• Lysine 8%
• Secondary Structure 8%
• Hydrophobicity 7%
• Mutation 7%
• Lipid 6%
• Purification 6%
• Solubility 5%
• Gel 5%
• Plasma 5%
• Reaction Yield 3%
• Acid 3%